Search Orphan Drug Designations and Approvals
-
Generic Name: | 2-(3-diethylaminopropyl)-8,8-dipropyl-2-azaspiro [4,5] decan dimaleate |
---|---|
Date Designated: | 12/02/2003 |
Orphan Designation: | Treatment of mulitple myeloma and associated bone resorption |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Callisto Pharmaceuticals, Inc. 2 Executive Drive Suite 450 Somerset, New Jersey 08873 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-